sucroferric oxyhydroxide (Velphoro)
Jump to navigation
Jump to search
Indications
- hyperphosphatemia in patients on hemodialysis
Dosage
- start: 500 mg PO TID with each meal
- tablets must be chewed not swallowed whole
- tablets may be crushed
- patients typically need 3 or 4 tablets/day
- maximum: 1000 mg TID
Tabs: 500 mg (chewable)
Adverse effects
Drug interactions
- coadministration of levothyroxine is contraindicated
- coadministration of vitamin D is contraindicated
- use caution with coadministation of alendronate or doxycycline
Notes
- cost $855/month 2014
More general terms
References
- ↑ Medscape: sucroferric oxyhydroxide http://reference.medscape.com/drug/velphoro-sucroferric-oxyhydroxide-999889
- ↑ Prescriber's Letter 21(4): 2014 Comparison of Phosphate Binders Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=300413&pb=PRL (subscription needed) http://www.prescribersletter.com